[1]
“COMPARATIVE IMMUNE MICROENVIRONMENT PROFILING IN HBV-, HCV-, AND DUAL-INFECTED HEPATOCELLULAR CARCINOMA: TOWARD ETIOLOGY-SPECIFIC IMMUNOTHERAPEUTIC TARGETS”, FMHR, vol. 3, no. 4, pp. 843–845, Jun. 2025, Accessed: Aug. 16, 2026. [Online]. Available: https://fmhr.net/index.php/fmhr/article/view/478